Attention%20deficit_hyperactivity%20disorder Signs and Symptoms

Signs and Symptoms

Introduction

Attention deficit/hyperactivity disorder (ADHD) is a neurobehavioral disorder that is marked by a pattern of inactivity, hyperactivity and impulsivity that affects the functioning and development of a child
ADHD is frequently present along with ≥1 of the following associated conditions:
- Learning disabilities (eg cognitive impairment, specific learning disorder, motor coordination problem, memory or auditory discriminatory problems)
- Speech and/or language delays
- Anxiety disorder
- Mania-bipolar disorder
- Autistic disorder
- Conduct disorder
- Depression
- Psychosis
- Oppositional defiant disorder
- Family and/or social problems
- Other medical problems (eg iron deficiency, lead toxicity, Tourette’s syndrome, tics, sleep apnea)

Signs and Symptoms

Hyperactivity
Acting without thinking
Inattention/daydreaming
Fidgety, restless
Difficulty in completing task
Excessive talking
Aggressive behavior
Academic underachievement
Disorganized
Impulsive behavior

Long COVID: What we have learned so far

Prof. Ghassan Dbaibo, 27 Apr 2023

The WHO defines long COVID as a condition that occurs 3 months from COVID-19 onset, whose symptoms last ≥2 months and cannot be attributed to an alternative diagnosis. In an interview with MIMS Doctor, Professor Ghassan Dbaibo of the Center for Infectious Diseases, American University of Beirut, Beirut, Lebanon, describes the evolving attitudes towards long COVID among healthcare professionals (HCPs), some unexpected predisposing factors, potential biological mechanisms behind prolonged symptom duration and shares data on vaccination’s protective effects against long COVID.

NCDs in Focus Act Now! Summit 2022

16 Mar 2023

Viatris, a global healthcare company, collaborated with the Thai Hypertension Society and the Thai NCD Collaboration Group to organize the NCDs in Focus Act Now! Summit 2022 in Bangkok on October 29^th and 30^th. This summit brought together nearly 300 multidisciplinary experts from Southeast Asia and India to address the unmet needs in managing two critical noncommunicable diseases (NCDs): cardiovascular diseases (CVDs) and mental health disorders (MHDs) in the region.

The summit had several key objectives. Firstly, it highlighted the effectiveness of clinical data in addressing gaps and unmet needs in clinical practice. Secondly, it emphasized the importance of sharing expertise and best practices through a platform that can optimize patient care. Additionally, it discussed the challenges of cardiovascular disease and mental health disorder care in a post COVID-19 world, and the need to re-examine them.

The summit also offered valuable insights into policy and practice changes, as well as innovative digital solutions that can lead to better outcomes. Lastly, it emphasized the significance of gaining a deeper understanding of the gaps in the patient journey to enhance patient care further.

Overall, the NCDs in Focus Act Now! Summit 2022 was a highly informative and productive event, with experts collaborating to improve the management of CVDs and MHDs in Southeast Asia and India.